Prednisolone is a glucocorticoid similar to cortisol used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.
Prednisolone was granted FDA approval on 21 June 1955.
Prednisolone is indicated to treat endocrine, rheumatic, and hematologic disorders; collagen, dermatologic, ophthalmic, respiratory, and gastrointestinal diseases; allergic and edematous states; and other conditions like tuberculous meningitis.
University Malaya Medical Centre, Kuala Lumpur, Malaysia
Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
KK Women's and Children's Hospital, Singapore, Singapore
University College London Hospitals NHS Foundation Trust, London, United Kingdom
The Royal Marsden Hospital, Sutton, United Kingdom
Royal Devon University Hospital Trust, Exeter, United Kingdom
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Albany Medical Center, Albany, New York, United States
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Faculty of Oral and Dental Medicine, Egyptian Russian University, Badr city, Cairo, Egypt
Faculty of Dentistry, Cairo University, Cairo, Egypt
Klinische Forschung Hannover Mitte GmbH/Pratia, Hannover, Germany
Emovis Gmbh, Berlin, Germany
Klinikum der Universität München, München, Germany
AIIMS Bhubaneswar, Bhubaneswar, Odisha, India
NL-Breda-AMPHIA, Breda, Netherlands
NL-Almelo-ZGTALMELO, Almelo, Netherlands
NL-Amstelveen-AMSTELLAND, Amstelveen, Netherlands
National Research Center for Hematology, Moscow, Russian Federation
Chest Clinic, Dept. of Pulmonary Medicine, Chandigarh, India
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.